ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,550 | -24.1% | 19,000 | -6.6% | 0.02% | -12.5% |
| Q2 2023 | $136,502 | -76.4% | 20,343 | -68.9% | 0.02% | -68.4% |
| Q1 2023 | $577,835 | +5.4% | 65,440 | -8.8% | 0.08% | +61.7% |
| Q4 2022 | $548,117 | +300.1% | 71,743 | +271.7% | 0.05% | +487.5% |
| Q3 2022 | $137,000 | -65.4% | 19,300 | +36.9% | 0.01% | -33.3% |
| Q4 2021 | $396,000 | – | 14,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |